BAC
Bank of America Corporation
BAC has the edge over UWMC overall, supported by lower modeled downside and stronger modeled upside.
UWMC
UWM Holdings Corporation
UWMC trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
UWMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
UWMC's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like UWMC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over UWMC in the historical PE scenario, which offers more potential upside but is not a forecast.
UWMC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $0.04 | -97% |
| Fair | 1.2x | $0.10 | -92% |
| Forward | 9.3x | $1.27 | — |
| Current | 16x | $1.27 | — |
| Expensive | 59x | $4.69 | +269% |
Historical ranges are pointers, not guarantees.
UWMC's PE is in its fair range at 16x. On analysts' estimates for next year's earnings, today's price would be 9.3x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over UWMC on the outlook, with more favorable earnings and revenue expectations.
UWMC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect UWMC's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
UWMC Earnings Per Share
UWMC and BAC do not have enough comparable growth data to identify a winner.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over UWMC on profitability, with a higher operating margin.
UWMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $811.1M | -3.8% |
| Q2 2026 | $888M | +17% |
| Q1 2026 | $901.4M | +47% |
| Q4 2025 | $945.2M | +69% |
| Q3 2025 | $843.3M | +60% |
| Q2 2025 | $758.7M | +50% |
| Q1 2025 | $613.4M | +7.6% |
| Q3 2024 | $526.4M | -22% |
UWMC's revenue is growing: $811M last quarter, down 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +26 points |
| Q2 2026 | -53% | -97 points |
| Q1 2026 | 20% | +62 points |
| Q4 2025 | 18% | +10 points |
| Q3 2025 | 1.5% | -4.6 points |
| Q2 2025 | 43% | +28 points |
| Q1 2025 | -43% | -75 points |
| Q4 2024 | 7.6% | N/A |
UWMC's operating margin was 28% last quarter, up 26 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over UWMC on cash generation, producing positive trailing cash flow while its opponent burns cash.
UWMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.2M | +$3.1B |
| Q2 2026 | $334.6M | +$624.6M |
| Q1 2026 | -$2.2B | -490% |
| Q4 2025 | $82M | +$633.6M |
| Q3 2025 | -$3.1B | -$899.1M |
| Q2 2025 | -$290.1M | +$1B |
| Q1 2025 | $576.1M | +$2.8B |
| Q3 2024 | -$2.2B | -745% |
UWMC's free cash flow was −$1.8B over the past year, against −$3.4B the year before. Free cash flow isn't a meaningful measure for financial services companies like UWMC.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over UWMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
UWMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +5.8M shares |
| 1 year | +70% | +141M shares |
UWMC has 343M diluted shares, up 70% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | $60.6M |
| Q3 2021 | $15.3M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over UWMC on leverage, with a lower net debt burden relative to earnings.
UWMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 16.2x | High |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 8.2x | High |
| Q3 2025 | 16.8x | High |
| Q2 2025 | 12.0x | High |
| Q4 2024 | 5.9x | High |
| Q3 2023 | 3.4x | Elevated |
| Q2 2023 | 3.4x | Elevated |
UWMC's net debt is about 16 years of its operating earnings (EBITDA), up from 12 years a year ago. Net leverage isn't a meaningful measure for financial services companies like UWMC.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
UWMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.7 | Neutral |
| Stochastic | 47.8 | Neutral |
UWMC's weekly RSI is 35 (neutral) and its Stochastic is 48 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over UWMC on valuation relative to its sector.
UWMC PE vs Financial Services Sector
| Metric | UWMC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 22% above |
| PE % | 54 | 64 | 10 pts below |
UWMC is trading at 16x earnings, a 22% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over UWMC on trend strength, trading above more of its moving averages.
UWMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.30 | 2.3% below |
| 20 week MA | $1.51 | 16% below |
| 50 week MA | $3.02 | 58% below |
| 100 week MA | $4.17 | 70% below |
| 200 week MA | $5.24 | 76% below |
UWMC is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over UWMC on returns for 2026, with the stronger performance.
UWMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.30 | $12.8 | +37% |
| 2021 | $12.8 | $6.38 | -50% |
| 2022 | $6.38 | $3.56 | -44% |
| 2023 | $3.56 | $7.15 | +101% |
| 2024 | $7.15 | $5.78 | -19% |
| 2025 | $5.78 | $4.59 | -21% |
| 2026 YTD | $4.59 | $1.27 | -72% |
UWMC's yearly returns have swung widely, from +101% in 2023 to −50% in 2021. It's down 72% so far in 2026.